ERBB2 and neoplasm: The membrane-restricted targeting strategy proposed in this study successfully breaks through the inherent limitations of the conventional ER/PR/HER2 detection framework by specifically identifying NCL proteins that are aberrantly overexpressed in tumor cell membranes.